Vion
Pharmaceuticals About
Vion Vion Pharmaceuticals, Inc. is a biotechnology company
that is developing novel agents for the treatment of cancer. We are evaluating
two small molecule anticancer compounds in human clinical trials. Additional small
molecule anticancer compounds are under development in preclinical studies.
Triapine® in Combination with Gemcitabine in Patients
with Pancreatic Cancer CLORETAZINE -- VNP40101M for Patients with Acute
Myelogenous Leukemia or High-Risk Myelodysplasia More
on
Vion Pharmaceuticals Key
Statistics for Vion
Basic
Chart for Vion